GL1X · GenesisL1 explorer

MolNFT v1 · #126948 · protein

BTGH84 mutant with covalent modification by MA4 in complex with pugnac

5MI7 · O-glcnacase BT_4395: “BTGH84 mutant with covalent modification by MA4 in complex with pugnac”. X-ray diffraction, 3 ligands (OAN, 7NT, CA), 8 pockets (best druggability 0.62). MolNFT v1 #126948 on GenesisL1: 3D structure, binding…

PDB
5MI7
Type
protein
Length
671 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
O-glcnacase BT_4395
EC
3.2.1.169, 3.2.1.52
UniProt
Q89ZI2
Ligands
OAN, 7NT, CA
Pockets
8 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AO-glcnacase BT_4395 (EC 3.2.1.169, 3.2.1.52)protein67140% helix, 19% strandQ89ZI2

Ligands and binding sites

  • OAN · O-(2-acetamido-2-deoxy D-glucopyranosylidene) amino-N-phenylcarbamate · ligand · chains A
  • 7NT · ~{N}-(4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl) propanamide · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13560.620.7846empty
2900.550.8519OAN
32000.450.7332empty
41040.380.7622empty
5790.360.7614empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5MI7 · BtGH84 mutant with covalent modification by MA4 in complex with PUGNAc · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.